The nursing caring for a client who experienced an ischemic stroke 8 hours ago recognizes that the medication being administered for the purpose of preventing further obstruction of vascular cerebral blood flow is: Select all that apply

Question

1. Intravenous heparin.
2. Subcutaneous low-molecular-weight heparin.
3. Intravenous mannitol.
4. Intravenous dopamine.
5. Subcutaneous insulin.

Answer 1

1. Intravenous heparin.
2. Subcutaneous low-molecular-weight heparin.

Rationale: Intravenous heparin. Anticoagulation with IV infusion of heparin for several days during the acute care management of a patient with ischemic stroke is common. Subcutaneous low-molecular-weight heparin. Some institutions use low-molecular-weight heparin (LMWH) subcutaneously instead of intravenous heparin. Intravenous mannitol. Intravenous mannitol is utilized to reduce intracranial pressure and brain mass. Intravenous dopamine. Intravenous dopamine is a vasopressor directed at stabilizing blood pressure. Subcutaneous insulin. Subcutaneous insulin may be used to manage hyperglycemia resulting from ineffective utilization of glucose.